Generics Dr. Reddy's Expands Commercial Operations of Generics in Europe
Dr. Reddy’s Laboratories announced the expansion of its commercial operations in Europe with the introduction of its portfolio of generics in France.
Basel/Switzerland — The first products will be made available in the hospital market in March 2017 in the area of oncology and anti-infectives, including antimycotics. The company recently launched select products of its hospital portfolio in Italy and Spain, and intends to strengthen its presence in the two countries with the launch of anti-HIV products this year. The pharmaceutical company is currently operating two R&D centres, one manufacturing, and a packaging and storage facility in Europe.